Bio-Rad Laboratories (BIO) Cost of Revenue (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Cost of Revenue of $282.7 million for Q1 2026, up 1.18% year-over-year from $279.4 million in Q1 2025, and down 18.76% quarter-over-quarter from $348.0 million in Q4 2025.
Bio-Rad Laboratories (BIO) Cost of Revenue (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Cost of Revenue for 18 consecutive years, with $282.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue rose 1.18% year-over-year to $282.7 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 5.45% YoY), while the FY2025 annual figure was $1.2 billion, up 4.69% from the prior year.
- Cost of Revenue declined to $282.7 million in Q1 2026 per BIO's latest filing, from $348.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $348.0 million in Q4 2025 and bottomed at $279.4 million in Q1 2025.
- Historically, Cost of Revenue has averaged $305.5 million across 5 years, with a median of $306.3 million in 2025.
- Annual changes were most pronounced in 2024 — Cost of Revenue fell 11.06% — and 2025, when it rose 8.08%.
- Bio-Rad Laboratories' Cost of Revenue stood at $333.2 million in 2022, then fell by 5.51% to $314.8 million in 2023, then climbed by 3.43% to $325.6 million in 2024, then rose by 6.88% to $348.0 million in 2025, then declined by 18.76% to $282.7 million in 2026.
- Business Quant data shows BIO's Cost of Revenue at $282.7 million in Q1 2026, $348.0 million in Q4 2025, and $309.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Bio-Rad Laboratories | 9.99 Bn | 8.37 Bn | 345.80 Mn | 305.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 305.20 Mn |
| Jun 30, 2026 | 305.20 Mn |
| Mar 31, 2026 | 282.70 Mn |
| Mar 31, 2026 | 282.70 Mn |
| Dec 31, 2025 | 348.00 Mn |
| Dec 31, 2025 | 348.00 Mn |
| Sep 30, 2025 | 309.60 Mn |
| Sep 30, 2025 | 309.60 Mn |
| Jun 30, 2025 | 306.30 Mn |
| Jun 30, 2025 | 306.30 Mn |
| Mar 31, 2025 | 279.40 Mn |
| Mar 31, 2025 | 279.40 Mn |
| Dec 31, 2024 | 325.60 Mn |
| Dec 31, 2024 | 325.60 Mn |
| Sep 30, 2024 | 293.80 Mn |
| Sep 30, 2024 | 293.80 Mn |
| Jun 30, 2024 | 283.40 Mn |
| Jun 30, 2024 | 283.40 Mn |
| Mar 31, 2024 | 284.90 Mn |
| Mar 31, 2024 | 284.90 Mn |